Pricing Log in Create free account
Saturday 17 October 2026 Export DCGO’s income statement to Excel — free account

DocGo Inc.

DCGO Healthcare Medical Care Facilities

DocGo Inc.’s revenue for fiscal 2025 (year ended December 2025) was $322.2 million, down 47.7% from fiscal 2024. In the quarter to June 2026, revenue fell 8.70%, EPS fell 45.5%, free cash flow fell 132.3% and total debt rose 7,140.9%, each against the same quarter a year earlier.

0.27 0.01 −3.57%
Market cap
$27.9M
P/E
0.0×
Fwd P/E
−1.6×
Dividend yield
—
F-score
3/9
Altman Z
−1.37
Beneish M
−8.29
Dividend safety
45/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.02
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — 1 — — — — — — — — — —
Insider Ownership 6.34%

Capital & Financial Ratios $m

Market Cap 27.92
Revenue 294.72
Net Income (206.69)
Free Cash Flow (28.57)
Net Debt (25.07)
Current Ratio 1.66 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E (1.62) (negative: loss-making)
P/S ratio 0.09
P/B ratio 0.28
Past 5Y EPS Growth —
This Y EPS Growth 72.42% (at or above 15%: strong)
Next Y EPS Growth 46.80% (at or above 15%: strong)
Next Y revenue growth (4.87%) (below 0%: weak)
Next 5Y EPS Growth 44.18% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.0×, against a ten-year median of 0.5×; over the ten years it ranged from 0.0× in 2026 to 1.9× in 2023.
P/S against its own 10 years 0.17%
10-year low 10-year high
P/B against its own 10 years 4.71%
10-year low 10-year high
EV/Sales against its own 10 years 0.17%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2022 Powerpack
2021 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 59 89 51 25
Receivables 262 211 93 86
Inventory — — — —
Other — 0 4 4
339 304 152 120
2023 2024 2025 Q'26
Payables 20 28 11 14
ST’ Debt — — — —
Other 28 5 3 9
170 122 67 72

Compound Annual Growth %

10y 5y 3y
Sales — 27.91% (9.90%)
Cash Flow — 0.00% 6.07%
Earnings — 0.00% 0.00%
Book Value — 13.46% (23.30%)

Revenue $m

Mar Jun Sep Dec Year
’26 76 73 — — —
’25 96 80 71 75 322
’24 192 165 139 121 617
’23 113 125 187 199 624
’22 118 110 104 109 441
’21 50 62 86 121 319
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (5) (9) — — —
’25 9 34 2 (10) 34
’24 (11) 37 31 13 70
’23 (23) 11 (46) (6) (64)
’22 18 12 7 (9) 29
’21 (1) 0 8 (9) (2)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (6) (10) — — —
’25 8 32 0 (13) 27
’24 (12) 35 30 12 65
’23 (26) 9 (47) (9) (74)
’22 17 11 5 (10) 23
’21 (3) (2) 7 (11) (9)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 (0.15) (0.16) — — —
’25 (0.09) (0.11) (0.28) (1.37) (1.84)
’24 0.10 0.06 0.05 (0.04) 0.18
’23 (0.03) (0.02) 0.05 0.07 0.06
’22 0.09 0.11 0.03 0.09 0.34
’21 (0.03) 1.13 0.01 0.21 0.25
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2.2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — 9.95 7.14 4.96 4.80 2.75 0.86

Analyst estimates 2026–2028

Powerpack
High — — — — 10.51 11.86 11.41 10.82 5.61 5.68
People
People Employees — — — — 4 2,924 3,252 4,164 4,407 3,568
Revenue/emp, $m — — — — 23.52 0.11 0.14 0.15 0.14 0.09
Income, $m
Income, $m Revenue — — — — 94 319 441 624 617 322
Gross margin, % — — — — 33.32 34.43 35.12 31.30 34.64 30.65
EBT — — — — (15) 20 23 16 28 (187)
EBT margin, % — — — — (15.55) 6.21 5.17 2.61 4.50 (58.19)
Net income — 0 — — (15) 19 31 10 13 (196)
Depreciation — — — — 6 7 13 16 16 74
Per share, $
Per share, $ Revenue — — — — 1.61 3.97 4.35 6.03 6.02 3.25
Earnings — — — — (0.25) 0.30 0.34 0.07 0.20 (1.84)
Cash flow — — — — (0.18) (0.02) 0.29 (0.62) 0.68 0.35
Capex — — — — (0.10) (0.08) (0.05) (0.09) (0.05) (0.07)
Free cash flow — — — — (0.29) (0.11) 0.23 (0.71) 0.63 0.27
Book value — — — — 1.15 2.83 2.76 2.95 3.08 1.27
Shares, m — — — — 58 80 101 104 102 99
Valuation, ×
Valuation, × P/E — — — — 0.00 7.10 20.53 73.86 22.32 0.00
P/S — — — — 0.00 2.36 1.70 0.86 0.70 0.27
P/B — — — — 2.18 3.31 2.68 1.75 1.38 0.69
EV/Sales — — — — 0.00 1.81 1.34 0.76 0.56 0.11
EV/FCF — — — — 0.00 (67.19) 25.33 (6.47) 5.32 1.34
Cash, $m
Cash, $m Operating cash flow — — — — (11) (2) 29 (64) 70 34
Capex — — — — (6) (7) (5) (9) (5) (7)
Free cash flow — — — — (17) (9) 23 (74) 65 27
Balance, $m
Balance, $m Working capital — — — — 35 198 171 169 183 85
Total debt — — — — 1 1 1 0 0 0
Net debt — — — — (32) (174) (156) (59) (89) (51)
Shareholders’ equity — — — — 67 227 279 305 315 126
Returns, %
Returns, % ROA — — — — (28.67) 11.59 9.84 1.55 4.23 (54.23)
ROIC — — — — (26.26) 18.17 11.11 3.83 7.94 (148.29)
ROE — — — — (10.46) 16.15 13.67 2.35 6.45 (82.71)
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

DocGo Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
JYNT The Joint Corp. $97.7M 26.0× 16.9× +14.41% (above 0%: growing) +400.00% (above 0%: growing) +432.31% (above 0%: growing) 83.68% (2.43%) Compare
PARK Park Dental Partners, Inc. $91.3M — (loss-making) — +12.15% (above 0%: growing) −65.84% (below 0%: shrinking) −34.78% (below 0%: shrinking) 14.37% 1.90% Compare
BTMD biote Corp. $39.9M 6.8× 11.0× −9.48% (below 0%: shrinking) n/m −174.16% (below 0%: shrinking) 65.38% (7.93%) Compare
PIII P3 Health Partners Inc. $30.1M — (loss-making) — +8.60% (above 0%: growing) n/m −272.24% (below 0%: shrinking) 22.26% 10.67% Compare
CCEL Cryo-Cell International Inc. $29.4M — (loss-making) 43.8× −0.02% (below 0%: shrinking) +77.78% (above 0%: growing) −58.37% (below 0%: shrinking) 79.38% 28.04% Compare
DCGO DocGo Inc. $27.9M — (loss-making) — (loss-making) −8.70% (below 0%: shrinking) n/m −132.28% (below 0%: shrinking) 30.52% (24.41%)
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR $15.9M — (loss-making) 8.3× +25,427.42% (above 0%: growing) n/m −206.36% (below 0%: shrinking) 42.70% (1.24%) Compare
CCM Concord Medical Services Holdings Limited $10.5M — (loss-making) — (loss-making) +37.65% (above 0%: growing) n/m −281.45% (below 0%: shrinking) (13.15%) 0.00% Compare
AMS American Shared Hospital Services $8.4M — (loss-making) 1.8× +19.22% (above 0%: growing) n/m +195.82% (above 0%: growing) 17.00% (7.22%) Compare
Median of peers $29.7M — 11.0× +13.28% +77.78% −116.26% 32.48% (0.62%)

All 55 Medical Care Facilities stocks →

DocGo Inc. (DCGO) key facts

  • Concern: DocGo Inc.’s revenue for fiscal 2025 (year ended December 2025) was $322.2 million, down 47.7% from fiscal 2024.
  • DocGo Inc. (DCGO) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, DCGO traded at $0.27, a market capitalization of $27.9 million.
  • Return on equity was −82.7% and debt-to-equity 0.00.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is −1.37 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

DocGo Inc. (DCGO) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/DCGO · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com